163 related articles for article (PubMed ID: 29305860)
1. RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells.
Zhong X; Lee HN; Surh YJ
Biochem Biophys Res Commun; 2018 Feb; 496(2):316-323. PubMed ID: 29305860
[TBL] [Abstract][Full Text] [Related]
2. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.
Lee HN; Surh YJ
Biochem Pharmacol; 2013 Sep; 86(6):759-69. PubMed ID: 23856291
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
Kang JW; Lee SM
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
7. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.
Shi H; Carion TW; Jiang Y; Steinle JJ; Berger EA
Prostaglandins Other Lipid Mediat; 2016 Mar; 123():28-32. PubMed ID: 27026343
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory actions of aspirin-triggered resolvin D1 (AT-RvD1) in bronchial epithelial cells stimulated by cigarette smoke extract.
de Oliveira JR; Pereira ABM; de Souza HI; Dos Santos WM; de Assunção TSF; de Vito FB; de Souza HM; da Silva PR; da Silva MV; Junior VR; Rogerio AP
Prostaglandins Other Lipid Mediat; 2024 Jun; 172():106833. PubMed ID: 38460760
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
[TBL] [Abstract][Full Text] [Related]
10. Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis.
Li A; Zhang L; Li J; Fang Z; Li S; Peng Y; Zhang M; Wang X
J Cell Mol Med; 2020 Nov; 24(22):13397-13407. PubMed ID: 33025767
[TBL] [Abstract][Full Text] [Related]
11. Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.
Liu GJ; Tao T; Wang H; Zhou Y; Gao X; Gao YY; Hang CH; Li W
J Neuroinflammation; 2020 Aug; 17(1):239. PubMed ID: 32795323
[TBL] [Abstract][Full Text] [Related]
12. Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis.
Zhao YL; Zhang L; Yang YY; Tang Y; Zhou JJ; Feng YY; Cui TL; Liu F; Fu P
Chin Med J (Engl); 2016 May; 129(9):1100-7. PubMed ID: 27098797
[TBL] [Abstract][Full Text] [Related]
13. Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice.
Zhang Z; Hu X; Qi X; Di G; Zhang Y; Wang Q; Zhou Q
Mol Vis; 2018; 24():274-285. PubMed ID: 29643724
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury.
Wang Q; Zheng X; Cheng Y; Zhang YL; Wen HX; Tao Z; Li H; Hao Y; Gao Y; Yang LM; Smith FG; Huang CJ; Jin SW
J Immunol; 2014 Apr; 192(8):3765-77. PubMed ID: 24646745
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1.
Hsiao HM; Thatcher TH; Levy EP; Fulton RA; Owens KM; Phipps RP; Sime PJ
J Immunol; 2014 Nov; 193(10):4980-7. PubMed ID: 25320283
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Activation Mechanism of the ALX/FPR2 Receptor.
Schmitz Nunes V; Rogério AP; Abrahão O
J Phys Chem Lett; 2020 Nov; 11(21):8952-8957. PubMed ID: 33030905
[TBL] [Abstract][Full Text] [Related]
17. Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality.
Lee HN; Choi YS; Kim SH; Zhong X; Kim W; Park JS; Saeidi S; Han BW; Kim N; Lee HS; Choi YJ; Baek JH; Na HK; Surh YJ
FASEB J; 2021 May; 35(5):e21432. PubMed ID: 33794029
[TBL] [Abstract][Full Text] [Related]
18. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
[TBL] [Abstract][Full Text] [Related]
20. Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.
Filiberto AC; Ladd Z; Leroy V; Su G; Elder CT; Pruitt EY; Hensley SE; Lu G; Hartman JB; Zarrinpar A; Sharma AK; Upchurch GR
FASEB J; 2022 Nov; 36(11):e22579. PubMed ID: 36183323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
